ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

5 hedge funds and large institutions have $12M invested in Esperion Therapeutics in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WA
1
Wasatch Advisors
Utah
$5.93M
2
MCM
2
Mazama Capital Management
Oregon
$2.14M
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$2.04M
4
LCS
4
Levin Capital Strategies
New York
$1.02M
5
WHI
5
William Harris Investors
Illinois
$916K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
WA
1
Wasatch Advisors
Utah
$5.93M 420,453 +420,453 New
MCM
2
Mazama Capital Management
Oregon
$2.14M 151,622 +151,622 New
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$2.04M 144,500 +144,500 New
LCS
4
Levin Capital Strategies
New York
$1.02M 72,133 +72,133 New
WHI
5
William Harris Investors
Illinois
$916K 65,000 +65,000 New